Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Chlorhexidine 0.03 mg/mL, disodium edetate 0.5 mg/mL, polyhexanide 0.005 mg/mL Solution, contact lens Bausch & Lomb Personal Products Division, Greenville, South Carolina, United States of America Boston Advance Conditioning Solution Mycophenolate mofetil 250 mg Capsule Syntex Puerto Rico Inc., Humacao, Puerto Rico CellCept Mycophenolate mofetil 500 mg Tablet Syntex Puerto Rico Inc., Humacao, Puerto Rico CellCept Etoposide 20 mg/mL in 5 mL and 25 mL Injection (vial) Delta West Pty Limited, Bentley, Western Australia, Australia Etoposide Injection Heparin sodium 5000 units in 1 mL and 5 mL Injection Delta West Pty Limited, Bentley, Western Australia, Australia Heparin Sodium Injection Daytime compontent: dextromethorphan hydrobromide 15 mg, paracetamol 325 mg, pseudoephedrine hydrochloride 30 mg; Nightime component: chlorpheniramine maleate 2 mg, dextromethorphan hydrobromide 15 mg, paracetamol 325 mg Caplets Sigma Pharmaceuticals Pty Limited, Croydon, Victoria, Australia Orthoxicol Day & Night Cold & Flu Sevoflurane 100% Liquid, volatile for inhalation Abbott Laboratories Limited, Queenborough, Kent, England and Abbott SpA., Latina, Italy Sevorane Polyhexanide 0.001 mg/mL in 120 mL, 250 mL, 360 mL Solution, contact lens Ciba Vision Ophthalmics GmbH, Munich, Germany Solo-care Soft Nonoxynol 9, 5% Condom Carter-Wallace Inc., Trenton, New Jersey, United States of America Trojan Regular with Spermicidal Lubricant Dated this 5th day of March 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection pursuant to delegation given by the Minister of Health on 18 January 1996.